23 June 2020

A new drug berzosertib has shown promising results in an early phase trial, as more than half of the 40 cancer patients given the drug had the growth of their tumours halted. One patient, diagnosed with ovarian cancer, saw her tumours shrink after combination treatment with berzosertib and chemotherapy. Research is ongoing into the effectiveness of berzosertib.


Read more here